What the Research Actually Says (and How to Tell Them Apart)
If you've shopped the Semax family, you've probably noticed three names that get used almost interchangeably, Semax, N-Acetyl Semax Amidate (NASA), and Adamax, plus a lot of vendors who can't agree on what's in the vial. They are not the same molecule, and the difference shows up cleanly on a Certificate of Analysis. Here's the research picture on each, then a quick-reference cheat sheet for reading your COA.
Semax
Semax is the parent compound: a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) built from the ACTH(4-7) fragment with a Pro-Gly-Pro tail bolted on to resist enzymatic breakdown. It was registered as a drug in Russia back in 1994 for ischemic stroke and cognitive impairment, which is why it has the deepest evidence base of the three.
What the research consistently shows:
- BDNF and NGF upregulation. The most consistently documented molecular mechanism of Semax is upregulation of BDNF and NGF in hippocampal and cortical tissue, the growth factors that underpin synaptic plasticity, learning, and memory consolidation.
- Monoamine modulation. Semax increases dopamine turnover in the striatum and prefrontal cortex and modulates serotonin metabolites across multiple brain regions, which lines up with its activating, focus-oriented profile in rodent models.
- Neuroprotection. In cerebral ischemia models it reduces infarct volume and upregulates anti-apoptotic Bcl-2 family members.
- No corticosteroid activity. Unlike its parent molecule ACTH, Semax has no corticosteroid-stimulating activity, you get the neurotrophic effects without the adrenal/cortisol axis being pulled in.
One honest caveat for the community: Western evidence is largely preclinical, and most human data comes from Russian-language clinical publications.
N-Acetyl Semax Amidate (NASA)
Same seven-amino-acid backbone, with two terminal modifications: an acetyl group on the N-terminus and amidation on the C-terminus. Those caps are the whole point, they shield the peptide from the aminopeptidases and carboxypeptidases that chew on the unprotected ends of regular Semax.
The research logic here is mostly pharmacokinetic rather than a separate mechanism. NASA shares Semax's BDNF/NGF-driven mechanism, but the terminal protection is intended to extend half-life and improve metabolic stability, which is why it's often the preferred intranasal form in research settings. Worth being straight about it though: there's far less direct published literature on NASA specifically than on plain Semax, most of its benefit profile is extrapolated from Semax plus the stability improvement.
Adamax
This is where it gets genuinely different. True Adamax (Ac-MEHFPGPAG-NH₂) is the Semax backbone with the N-terminal/C-terminal modifications plus an adamantane-containing group. It's described as Semax modified with the N-terminal and C-terminal modifications found in Peptide 021 (P21), the adamantane portion is essentially borrowed from that neurogenic peptide.
Why the adamantane cage matters: it's the same lipophilic motif found in approved CNS drugs like amantadine and memantine. The adamantane modification enhances lipophilicity, improves blood-brain-barrier penetration, extends half-life, and stabilizes the peptide against enzymatic degradation. In preclinical work, Adamax increases BDNF levels and enhances hippocampal TrkB receptor sensitivity, and it's frequently described as the most potent and longest-acting member of the Semax family.
Two responsible notes for a research-first audience:
- The published literature on Adamax specifically is the thinnest of the three — most claims rest on the Semax evidence base plus the known behavior of adamantane modifications, not on Adamax-specific human trials.
- Adamax has been identified as a designer drug in border seizures and suggested for classification as a prescription medicine in New Zealand. It is very much an investigational, research-use-only compound.
The non-adamantane "Adamax-like" variant — buyer beware
There's a fourth thing floating around: an extended Semax sequence (the protected, amidated backbone) sold as "Adamax" but without the adamantane group. Chemically it's a different molecule from the 1032 Da version. The fact that vendor molecular-weight listings for "Adamax" are all over the map is exactly why the COA matters more than the label.
Quick Key Takeaways
Regular Semax
- Molecular Weight: 813.93 g/mol
- The original 7-amino-acid Semax peptide
- Smallest and simplest version
N-Acetyl Semax Amidate (NASA)
- Molecular Weight: 854.97 g/mol
- Same Semax peptide with N-terminal acetylation + C-terminal amidation
- About 41 Da heavier than regular Semax
- The terminal modifications are intended to improve stability and resistance to breakdown
Adamax (Adamantane Version)
- Molecular Weight: 1032.24 g/mol
- The same protected Semax backbone plus an adamantane-containing modification
- Roughly 177 Da heavier than NASA
- This is the "true" Adamax most people are referring to
Non-Adamantane "Adamax-like" Variants
- Molecular Weight: ~983–984 g/mol
- Usually an extended Semax sequence without the adamantane modification
- Despite sometimes being sold as "Adamax," these are chemically different from the 1032 Da version
Why the Molecular Weight Matters
If you get lab testing or a Certificate of Analysis back, the mass tells you what you actually have:
- ~814 Da → Regular Semax
- ~855 Da → N-Acetyl Semax Amidate (NASA)
- ~983–984 Da → Extended Semax sequence without adamantane
- ~1032 Da → True adamantane Adamax
Biggest Takeaways
- Semax is the original peptide — and the one with the deepest research base.
- NASA is Semax with stability-enhancing terminal modifications; same mechanism, better durability.
- True Adamax is a substantially different molecule because the adamantane modification pushes its weight to 1032.24 Da and changes its lipophilicity and BBB profile.
- Some vendors label ~983–984 Da compounds as "Adamax," but those don't appear to be the same molecule as the 1032.24 Da adamantane version.
- Molecular weight is one of the easiest, hardest-to-fake ways to confirm which version is actually in your vial.